日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A cause and protective treatment for acute and progressive disability and grey matter atrophy

急性进行性残疾和灰质萎缩的病因及保护性治疗方法

Aguzzi, Erika A; Desai, Roshni A; Yang, Zhiyuan; Davies, Andrew L; Mahad, Don; Siow, Bernard; Yenicelik, Ayse G; Desai, Radha; Giama, Eleni; Almasri, AlBeshr; Colman, Miranda; Geywitz, Celine; Schirmer, Lucas; Felts, Paul A; Smith, Kenneth J

The mGluR5 Agonist, CHPG, Enhances Numbers of Differentiated Human Oligodendrocytes.

mGluR5激动剂CHPG可增加分化的人类少突胶质细胞的数量

Huang Yangyang, Geywitz Celine, Bandaru Anjalika, Glass Ian A, Schirmer Lucas, Nobuta Hiroko, Dreyfus Cheryl